{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Pargyline : Questions médicales les plus fréquentes",
"headline": "Pargyline : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Pargyline : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-21",
"dateModified": "2026-03-11",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Pargyline"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Benzylamines",
"url": "https://questionsmedicales.fr/mesh/D001596",
"about": {
"@type": "MedicalCondition",
"name": "Benzylamines",
"code": {
"@type": "MedicalCode",
"code": "D001596",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.140.210"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Pargyline",
"alternateName": "Pargyline",
"code": {
"@type": "MedicalCode",
"code": "D010293",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "E A Kulikova",
"url": "https://questionsmedicales.fr/author/E%20A%20Kulikova",
"affiliation": {
"@type": "Organization",
"name": "Federal research center Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences, Novosibirsk, 630090 Russia."
}
},
{
"@type": "Person",
"name": "D V Fursenko",
"url": "https://questionsmedicales.fr/author/D%20V%20Fursenko",
"affiliation": {
"@type": "Organization",
"name": "Federal research center Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences, Novosibirsk, 630090 Russia."
}
},
{
"@type": "Person",
"name": "E Yu Bazhenova",
"url": "https://questionsmedicales.fr/author/E%20Yu%20Bazhenova",
"affiliation": {
"@type": "Organization",
"name": "Federal research center Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences, Novosibirsk, 630090 Russia."
}
},
{
"@type": "Person",
"name": "A V Kulikov",
"url": "https://questionsmedicales.fr/author/A%20V%20Kulikov",
"affiliation": {
"@type": "Organization",
"name": "Federal research center Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences, Novosibirsk, 630090 Russia."
}
},
{
"@type": "Person",
"name": "Qiu-Qin Huang",
"url": "https://questionsmedicales.fr/author/Qiu-Qin%20Huang",
"affiliation": {
"@type": "Organization",
"name": "MOE Key Laboratory for Analytical Science of Food Safety and Biology, Fujian Provincial Key Laboratory of Analysis and Detection Technology for Food Safety, Fujian Provincial Key Laboratory of Electrochemical Energy Storage Materials, College of Chemistry, Fuzhou University, Fuzhou, Fujian 350108, China. qhw76@fzu.edu.cn."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Perivascular invasion of primary human glioblastoma cells in organotypic human brain slices: human cells migrating in human brain.",
"datePublished": "2023-07-25",
"url": "https://questionsmedicales.fr/article/37490233",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11060-023-04349-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Human",
"datePublished": "2024-05-29",
"url": "https://questionsmedicales.fr/article/38807524",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1098/rsif.2024.0074"
}
},
{
"@type": "ScholarlyArticle",
"name": "On human-in-the-loop optimization of human-robot interaction.",
"datePublished": "2024-09-25",
"url": "https://questionsmedicales.fr/article/39322732",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41586-024-07697-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Development of a thermodynamics of human cognition and human culture.",
"datePublished": "2023-08-14",
"url": "https://questionsmedicales.fr/article/37573880",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1098/rsta.2022.0378"
}
},
{
"@type": "ScholarlyArticle",
"name": "Industry 5 and the Human in Human-Centric Manufacturing.",
"datePublished": "2023-07-14",
"url": "https://questionsmedicales.fr/article/37514710",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/s23146416"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés chimiques organiques",
"item": "https://questionsmedicales.fr/mesh/D009930"
},
{
"@type": "ListItem",
"position": 3,
"name": "Hydrocarbures",
"item": "https://questionsmedicales.fr/mesh/D006838"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hydrocarbures cycliques",
"item": "https://questionsmedicales.fr/mesh/D006844"
},
{
"@type": "ListItem",
"position": 5,
"name": "Hydrocarbures aromatiques",
"item": "https://questionsmedicales.fr/mesh/D006841"
},
{
"@type": "ListItem",
"position": 6,
"name": "Dérivés du benzène",
"item": "https://questionsmedicales.fr/mesh/D001555"
},
{
"@type": "ListItem",
"position": 7,
"name": "Composés benzyliques",
"item": "https://questionsmedicales.fr/mesh/D001593"
},
{
"@type": "ListItem",
"position": 8,
"name": "Benzylamines",
"item": "https://questionsmedicales.fr/mesh/D001596"
},
{
"@type": "ListItem",
"position": 9,
"name": "Pargyline",
"item": "https://questionsmedicales.fr/mesh/D010293"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Pargyline - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Pargyline",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-05-15",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Pargyline",
"description": "Comment diagnostiquer une surdose de pargyline ?\nQuels tests sont utilisés pour évaluer l'effet de la pargyline ?\nQuels symptômes indiquent un besoin de pargyline ?\nComment évaluer l'efficacité de la pargyline ?\nQuels signes cliniques nécessitent un ajustement de dose ?",
"url": "https://questionsmedicales.fr/mesh/D010293?mesh_terms=Humans#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Pargyline",
"description": "Quels sont les effets secondaires courants de la pargyline ?\nLa pargyline peut-elle causer des troubles du sommeil ?\nQuels symptômes indiquent une réaction allergique à la pargyline ?\nLa pargyline peut-elle provoquer des palpitations ?\nQuels symptômes nécessitent une consultation médicale urgente ?",
"url": "https://questionsmedicales.fr/mesh/D010293?mesh_terms=Humans#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Pargyline",
"description": "Comment prévenir les effets secondaires de la pargyline ?\nQuelles précautions prendre avant de commencer la pargyline ?\nLa pargyline nécessite-t-elle un régime alimentaire particulier ?\nComment éviter les interactions médicamenteuses avec la pargyline ?\nQuels conseils donner aux patients sous pargyline ?",
"url": "https://questionsmedicales.fr/mesh/D010293?mesh_terms=Humans#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Pargyline",
"description": "Comment la pargyline est-elle administrée ?\nLa pargyline peut-elle être combinée avec d'autres médicaments ?\nQuel est le dosage habituel de pargyline ?\nQuels sont les traitements alternatifs à la pargyline ?\nComment surveiller les effets de la pargyline ?",
"url": "https://questionsmedicales.fr/mesh/D010293?mesh_terms=Humans#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Pargyline",
"description": "Quelles sont les complications possibles de la pargyline ?\nComment gérer une hypertension causée par la pargyline ?\nLa pargyline peut-elle entraîner des troubles psychologiques ?\nQuels signes indiquent une complication grave de la pargyline ?\nComment prévenir les complications liées à la pargyline ?",
"url": "https://questionsmedicales.fr/mesh/D010293?mesh_terms=Humans#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Pargyline",
"description": "Quels facteurs augmentent le risque d'effets secondaires de la pargyline ?\nLes antécédents d'AVC sont-ils un facteur de risque pour la pargyline ?\nLe diabète est-il un facteur de risque pour la pargyline ?\nLes femmes enceintes doivent-elles éviter la pargyline ?\nQuels médicaments augmentent le risque d'interactions avec la pargyline ?",
"url": "https://questionsmedicales.fr/mesh/D010293?mesh_terms=Humans#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une surdose de pargyline ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic repose sur les symptômes cliniques et l'historique médicamenteux."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'effet de la pargyline ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de pression artérielle et des évaluations neurologiques sont courants."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un besoin de pargyline ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes de la maladie de Parkinson, comme les tremblements et la rigidité, sont indicatifs."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'efficacité de la pargyline ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité est évaluée par l'amélioration des symptômes moteurs et de la qualité de vie."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques nécessitent un ajustement de dose ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes d'hypertension ou d'effets secondaires neurologiques peuvent nécessiter un ajustement."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires courants de la pargyline ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires incluent des maux de tête, des vertiges et des nausées."
}
},
{
"@type": "Question",
"name": "La pargyline peut-elle causer des troubles du sommeil ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles du sommeil comme l'insomnie peuvent survenir avec la pargyline."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une réaction allergique à la pargyline ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des éruptions cutanées, des démangeaisons ou un gonflement peuvent indiquer une allergie."
}
},
{
"@type": "Question",
"name": "La pargyline peut-elle provoquer des palpitations ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des palpitations cardiaques peuvent être un effet secondaire de la pargyline."
}
},
{
"@type": "Question",
"name": "Quels symptômes nécessitent une consultation médicale urgente ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs thoraciques, des difficultés respiratoires ou des symptômes neurologiques graves."
}
},
{
"@type": "Question",
"name": "Comment prévenir les effets secondaires de la pargyline ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical régulier et un ajustement de la dose peuvent aider à prévenir les effets secondaires."
}
},
{
"@type": "Question",
"name": "Quelles précautions prendre avant de commencer la pargyline ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Informez votre médecin de vos antécédents médicaux et des médicaments en cours."
}
},
{
"@type": "Question",
"name": "La pargyline nécessite-t-elle un régime alimentaire particulier ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il est conseillé d'éviter les aliments riches en tyramine pour prévenir les interactions."
}
},
{
"@type": "Question",
"name": "Comment éviter les interactions médicamenteuses avec la pargyline ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Discutez toujours avec votre médecin avant d'ajouter un nouveau médicament à votre traitement."
}
},
{
"@type": "Question",
"name": "Quels conseils donner aux patients sous pargyline ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Informez-vous sur les effets secondaires et signalez tout symptôme inhabituel à votre médecin."
}
},
{
"@type": "Question",
"name": "Comment la pargyline est-elle administrée ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "La pargyline est généralement administrée par voie orale sous forme de comprimés."
}
},
{
"@type": "Question",
"name": "La pargyline peut-elle être combinée avec d'autres médicaments ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, mais il faut éviter les autres IMAO et certains antidépresseurs pour prévenir les interactions."
}
},
{
"@type": "Question",
"name": "Quel est le dosage habituel de pargyline ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le dosage habituel commence souvent à 10 mg par jour, ajusté selon la réponse clinique."
}
},
{
"@type": "Question",
"name": "Quels sont les traitements alternatifs à la pargyline ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "D'autres IMAO ou médicaments dopaminergiques peuvent être envisagés comme alternatives."
}
},
{
"@type": "Question",
"name": "Comment surveiller les effets de la pargyline ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La surveillance inclut des contrôles réguliers de la pression artérielle et des évaluations neurologiques."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles de la pargyline ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'hypertension, les troubles neurologiques et les réactions allergiques."
}
},
{
"@type": "Question",
"name": "Comment gérer une hypertension causée par la pargyline ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est crucial de consulter un médecin pour ajuster le traitement et surveiller la pression."
}
},
{
"@type": "Question",
"name": "La pargyline peut-elle entraîner des troubles psychologiques ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles comme l'anxiété ou la dépression peuvent survenir chez certains patients."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une complication grave de la pargyline ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes tels que des douleurs thoraciques ou des troubles de la vision nécessitent une attention immédiate."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications liées à la pargyline ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi régulier et une communication ouverte avec le médecin sont essentiels pour prévenir les complications."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque d'effets secondaires de la pargyline ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge avancé, les maladies cardiovasculaires et la prise d'autres médicaments augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les antécédents d'AVC sont-ils un facteur de risque pour la pargyline ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les antécédents d'AVC peuvent augmenter le risque de complications avec la pargyline."
}
},
{
"@type": "Question",
"name": "Le diabète est-il un facteur de risque pour la pargyline ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le diabète peut augmenter le risque d'effets indésirables lors de l'utilisation de pargyline."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes doivent-elles éviter la pargyline ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la pargyline est généralement contre-indiquée pendant la grossesse en raison des risques potentiels."
}
},
{
"@type": "Question",
"name": "Quels médicaments augmentent le risque d'interactions avec la pargyline ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antidépresseurs, les autres IMAO et certains analgésiques peuvent augmenter ce risque."
}
}
]
}
]
}
MOE Key Laboratory for Analytical Science of Food Safety and Biology, Fujian Provincial Key Laboratory of Analysis and Detection Technology for Food Safety, Fujian Provincial Key Laboratory of Electrochemical Energy Storage Materials, College of Chemistry, Fuzhou University, Fuzhou, Fujian 350108, China. qhw76@fzu.edu.cn.
MOE Key Laboratory for Analytical Science of Food Safety and Biology, Fujian Provincial Key Laboratory of Analysis and Detection Technology for Food Safety, Fujian Provincial Key Laboratory of Electrochemical Energy Storage Materials, College of Chemistry, Fuzhou University, Fuzhou, Fujian 350108, China. qhw76@fzu.edu.cn.
MOE Key Laboratory for Analytical Science of Food Safety and Biology, Fujian Provincial Key Laboratory of Analysis and Detection Technology for Food Safety, Fujian Provincial Key Laboratory of Electrochemical Energy Storage Materials, College of Chemistry, Fuzhou University, Fuzhou, Fujian 350108, China. qhw76@fzu.edu.cn.
MOE Key Laboratory for Analytical Science of Food Safety and Biology, Fujian Provincial Key Laboratory of Analysis and Detection Technology for Food Safety, Fujian Provincial Key Laboratory of Electrochemical Energy Storage Materials, College of Chemistry, Fuzhou University, Fuzhou, Fujian 350108, China. qhw76@fzu.edu.cn.
MOE Key Laboratory for Analytical Science of Food Safety and Biology, Fujian Provincial Key Laboratory of Analysis and Detection Technology for Food Safety, Fujian Provincial Key Laboratory of Electrochemical Energy Storage Materials, College of Chemistry, Fuzhou University, Fuzhou, Fujian 350108, China. qhw76@fzu.edu.cn.
MOE Key Laboratory for Analytical Science of Food Safety and Biology, Fujian Provincial Key Laboratory of Analysis and Detection Technology for Food Safety, Fujian Provincial Key Laboratory of Electrochemical Energy Storage Materials, College of Chemistry, Fuzhou University, Fuzhou, Fujian 350108, China. qhw76@fzu.edu.cn.
State Key Laboratory of Structural Chemistry, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou, Fujian 350002, China.
Graduate Institute of Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 110031, Taiwan.
TMU Research Center of Drug Discovery, Taipei Medical University, Taipei 110031, Taiwan.
Ph.D. Program in Drug Discovery and Development Industry, College of Pharmacy, Taipei Medical University, Taipei 110031, Taiwan.
Master Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 110031, Taiwan.
Graduate Institute of Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 110031, Taiwan.
TMU Research Center of Drug Discovery, Taipei Medical University, Taipei 110031, Taiwan.
Ph.D. Program in Drug Discovery and Development Industry, College of Pharmacy, Taipei Medical University, Taipei 110031, Taiwan.
Glioblastoma (GBM) is an aggressive primary brain cancer. Lack of effective therapy is related to its highly invasive nature. GBM invasion has been studied with reductionist systems that do not fully ...
Non-tumor brain samples were obtained from patients undergoing surgery (n = 7). Organotypic brain slices were prepared, and green fluorescent protein (GFP)-labeled primary human GBM IDH-wild type cell...
After placement, cells migrated towards blood vessels; initially migrating with limited directionality, sending processes in different directions, and increasing their speed upon contact with the vess...
Human organotypic models can accurately study cell migration ex vivo. GBM IDH-wild type cells migrate toward the perivascular space in blood vessels and their migratory parameters change once they con...
The interaction among joints of the midtarsal complex and subtalar joint is important for locomotor function; however, its complexity poses substantial challenges in quantifying the joints' motions. W...
From industrial exoskeletons to implantable medical devices, robots that interact closely with people are poised to improve every aspect of our lives. Yet designing these systems is very challenging; ...
Inspired by foundational studies in classical and quantum physics, and by information retrieval studies in quantum information theory, we prove that the notions of 'energy' and 'entropy' can be consis...
Industry 4 (I4) was a revolutionary new stage for technological progress in manufacturing which promised a new level of interconnectedness between a diverse range of technologies. Sensors, as a point ...
As the global population rapidly ages with longer life expectancy and declining birth rates, the need for healthcare services and caregivers for older adults is increasing. Current research envisions ...
Bowers et al. express skepticism about deep neural networks (DNNs) as models of human vision due to DNNs' failures to account for results from psychological research. We argue that to fairly assess DN...
Humans can easily perform various types of hugs in human contact and affection experience. With the prevalence of robots in social applications, they would be expected to possess the capability of hug...
All human groups are equally human, but are they automatically represented as such? Harnessing data from 61,377 participants across 13 experiments (six primary and seven supplemental), a sharp dissoci...
Allogeneic stem cell transplantation (alloSCT) can be curative for hemato-oncology patients due to effective graft-versus-tumor immunity. However, relapse remains the major cause of treatment failure,...